Neogen Chemicals Ltd
Complete IPO details, including price band, financials, subscription status, and key insights.
Participate in the Neogen Chemicals Ltd IPO with full transparency. Review issue details, company fundamentals, and financial performance, and apply securely through Alice Blue.
Financial Performance
Revenue, profit after tax and total assets across the last 3 reported financial years.
Revenue
Amount in ₹ crore
Profit After Tax (PAT)
Amount in ₹ crore
Total Assets
Amount in ₹ crore
Figures in ₹ crore, on a consolidated basis, as reported for FY24 to FY26.
Objects of the Issue
How the company plans to utilize IPO proceeds.
Use of Proceeds
The funds raised through this IPO will be used for:
Initial Public Offer of 6,155,813 equity shares* of face value of Rs.10 each (equity shares) of Neogen Chemicals Limited (the company) for cash at a price of Rs. 215 per equity share (including a share premium of Rs. 205 per equity share) aggregating Rs. 132.35 Crores* (offer). The offer comprises of a fresh issue of 3,255,813 equity shares aggregating Rs. 70 Crores by the company (fresh issue) and an offer for sale of 1,699,600 equity shares by haridas thakarshi kanani (promoter selling shareholder) and 1,200,400 equity shares by beena haridas kanani ("promoter group selling shareholder", and along with the promoter selling shareholder collectively referred to as the "selling shareholders") aggregating Rs. 62.35 Crores (offer for sale). The offer constitutes 26.38%* of the post-offered paid up equity share capital of the company. *subject to finalisation of basis of allotment The face value of the equity shares is Rs.10 each. The Issue price is Rs. 215 and the offer price is 21.50 times the face value of the equity shares. Bids can be made for a minimum of 65 Equity Shares and in multiples of 65 Equity Shares thereafter.
*Subject to approvals and market conditions.
Strengths & Risks
Key competitive advantages and factors to consider before investing.
- Neogen Corporation has filed a commercial intellectual property suit against Company which if determined against Company may have an adverse effect on this Offer, its business and results of operations.
- There are proceedings pending against Company and Directors which if determined against Company or these directors, may have an adverse effect on its business and results of operations.
- Company is heavily reliant on the demand from application industries such as pharmaceuticals, agrochemicals, refrigeration and construction chemicals. Any downturn in the application industries could have an adverse impact on Company's business and results of operations.
- Company does not have long-term agreements with suppliers for its raw materials and an increase in the cost of, or a shortfall in the availability or quality of such raw materials could have an adverse effect on its business and results of operations.
- This Prospectus contains information from an industry report which it have commissioned from CRISIL Research.